title: Investigation of +405 and -460 polymorphisms of vascular endothelial growth factor in psoriasis and short-term responsiveness to efalizumab therapy.
authors.forename: I
authors.initials: I
authors.lastname: Stefanaki
authors.forename: G
authors.initials: G
authors.lastname: Dimisianos
authors.forename: C
authors.initials: C
authors.lastname: Antoniou
authors.forename: A
authors.initials: A
authors.lastname: Katsambas
authors.forename: A
authors.initials: A
authors.lastname: Stratigos
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide; D011565:Psoriasis / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; C472181:efalizumab